Showing 12 of 12 recruiting trials for “Stargardt disease”
RecruitingNCT07425574 ↗
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
👨⚕️ Medical Director, Astellas Pharma Global Development, Inc.📍 1 site📅 Started Feb 2026View details ↗
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
A Study of DC6001 Tablet in Healthy Chinese Adult Subjects
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
RecruitingNCT06445322 ↗
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
RecruitingNCT06591806 ↗
An Observational Study in Children and Adults With Stargardt Disease
RecruitingNCT06435000 ↗
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Oral Metformin for Treatment of ABCA4 Retinopathy
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →